Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two diphencyprone regimens in alopecia areata
IRCT20141209020250N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diphencyprone in alopecia areata (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Hair regrowth rate, Change in SALT score and 3 more. Started Nov 2019; status: completed.
02
Drugs
diphencyprone
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20141209020250N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020250N5.